Download
s10792-021-01755-8.pdf 316,17KB
WeightNameValue
1000 Titel
  • Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study
1000 Autor/in
  1. Joachimsen, Lutz |
  2. Farassat, Navid |
  3. Bleul, Tim |
  4. Böhringer, Daniel |
  5. Lagrèze, Wolf A. |
  6. Reich, Michael |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-25
1000 Erschienen in
1000 Quellenangabe
  • 41(6):2001-2008
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s10792-021-01755-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172502/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!Based on findings of the Asian low-concentration atropine for myopia progression study, a concentration of 0.05% has been proposed as a good compromise between safety and efficacy for myopia control. However, no data on side effects have been published so far in Caucasian children receiving this dose.!##!Methods!#!Prior to commencement of bilateral atropine treatment with 0.05% atropine, 19 myopic children aged 5 to 15 years were treated in only one eye at bedtime leaving the other eye as a control. Pupil size, accommodation amplitude and near visual acuity were measured at 10:00 a.m. the next day and compared to the untreated contralateral control eye. The results were then compared to a cohort of 18 children whose treatment with 0.01% atropine commenced in a similar fashion.!##!Results!#!Twelve children (63%) reported visual impairment or reading difficulties. Anisocoria was 2.9 ± 1.1 mm. In comparison, 0.01% atropine led to a significantly less anisocoria of 0.8 ± 0.7 mm (p < 0.0001). Accommodation was decreased by - 4.2 ± 3.8 D in 0.05% atropine treated eyes, whereas 0.01% atropine induced hypoaccommodation of - 0.05 ± 2.5 D (p < 0.01). Near visual acuity was not significantly reduced in eyes treated with 0.05% atropine compared to 0.01% atropine (p = 0.26).!##!Conclusion!#!Compared to 0.01%, our data indicate stronger more relevant side effects of 0.05% topical atropine in young Caucasian children with progressive myopia as recently reported in Asian children, potentially compromising acceptance and compliance.
1000 Sacherschließung
lokal Double-Blind Method [MeSH]
lokal Disease Progression [MeSH]
lokal Humans [MeSH]
lokal Mydriatics [MeSH]
lokal Myopia
lokal Low-dose atropine
lokal Schools [MeSH]
lokal Atropine [MeSH]
lokal Ophthalmic Solutions [MeSH]
lokal Children
lokal Original Paper
lokal Pilot Projects [MeSH]
lokal Caucasian
lokal Child [MeSH]
lokal Europe
lokal Side effects
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Sm9hY2hpbXNlbiwgTHV0eg==|https://frl.publisso.de/adhoc/uri/RmFyYXNzYXQsIE5hdmlk|https://frl.publisso.de/adhoc/uri/QmxldWwsIFRpbQ==|https://frl.publisso.de/adhoc/uri/QsO2aHJpbmdlciwgRGFuaWVs|https://frl.publisso.de/adhoc/uri/TGFncsOoemUsIFdvbGYgQS4=|https://orcid.org/0000-0002-9813-8483
1000 Hinweis
  • DeepGreen-ID: c080052f82a446f7b9ea4567ac651c61 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6444921.rdf
1000 Erstellt am 2023-04-27T14:55:10.744+0200
1000 Erstellt von 322
1000 beschreibt frl:6444921
1000 Zuletzt bearbeitet 2023-10-20T14:18:09.161+0200
1000 Objekt bearb. Fri Oct 20 14:18:09 CEST 2023
1000 Vgl. frl:6444921
1000 Oai Id
  1. oai:frl.publisso.de:frl:6444921 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source